Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 164
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Quarterly Psychedelics Briefing: Q3 2026
Weekly Psychedelic Policy Briefing, September 21, 2026
Health Canada Authorizes Optimi’s Natural Psilocybin Trial as House Bill Targets Botanical Drug Exclusivity
Pα+ Psychedelic Bulletin #232: Q2’26 Psychedelic Lobbying Update; DEA Again Moves to Schedule 5 Tryptamines; Oregon Backpedals Psilocybin Fee Hike
Podcast: Psychedelics in D.C., FDA’s Framework, and New Zealand’s MDMA Prescribers
Numinus to Participate in the Cantor Neurology & Psychiatry Conference on...
PT360 – Stephanie Wang – Kanna: Love and Wholeness Through Nature’s...
PharmaTher Provides Business Highlights and Releases Audited Annual Financials for Fiscal...
Reunion Neuroscience Inc. Appoints Greg Mayes as President and Chief Executive...
MindMed Announces Pricing of Public Offering of Common Shares and Warrants
Mindset Pharma Provides Strategic Intellectual Property License to Cybin
Silo Pharma Announces Uplisting to Nasdaq Capital Market and Pricing of...
MindMed Announces Proposed Public Offering of Common Shares
BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives
atai Life Sciences Announces Initiation of Phase 1 Trial for its...
Load more